Concepedia

Retinopathy and RAAS Activation: Results From the Canadian Study of Longevity in Type 1 Diabetes

Julie A. Lovshin, Yuliya Lytvyn, Leif E. Lovblom, Alexandra Katz, Geneviève Boulet, Petter Bjornstad, Vesta Lai, Leslie Cham, Josephine Tse, Andrej Orszag,

Diabetes Care · 2018 · 31 citations · 29 references

DOIFull text

Open access

Abstract

PDR was associated with neuropathy severity and cardiovascular and peripheral vascular disease. In those with PDR, RAAS activation may be linked to vascular stiffening, an effect that persists in long-standing type 1 diabetes.

References

29

Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

Tamara Isakova · JAMA · 2011 · 989 citations · Full text

Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes

Michael Mauer, Bernard Zinman, Robert Gardiner et al. · New England Journal of Medicine · 2009 · 783 citations · Full text

Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications

William H. Herman, Rodica Pop‐Busui, Barbara H. Braffett et al. · Diabetic Medicine · 2012 · 466 citations · Full text

EVALUATION OF RENAL RESISTANCES, WITH SPECIAL REFERENCE TO CHANGES IN ESSENTIAL HYPERTENSION 1

Domingo M. Gómez · Journal of Clinical Investigation · 1951 · 250 citations · Full text

, , +8

Diabetic Retinopathy

Donald S. Fong, Lloyd Paul Aiello, Thomas W. Gardner et al. · Diabetes Care · 2003 · 225 citations · Full text